| Issue Type | XXXX |
|---|---|
| Country | Switzerland |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2031-11-17 |
| Par Value | 5000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 350.00 |
| Coupon | 2.6 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 350 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Sandoz Group AG corporate bond has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million CHF and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Sandoz Group AG, founded in 1886 and headquartered in Holzkirchen, Germany, is a global leader in the pharmaceutical industry, specializing in generic and biosimilar medicines designed to enhance patient access to essential healthcare. The company offers a diverse portfolio of high-quality, cost-effective pharmaceuticals, addressing various therapeutic areas such as oncology, cardiology, and immunology.